experiment
clinic
evid
present
support
hypothesi
lymphocyt
aim
suppress
hiv
replic
infect
cell
may
import
role
pathogeresi
aid
directli
caus
decreas
lymphocyt
number
possibl
model
test
hypothesi
discuss
life
cycl
retroviru
newli
infect
cell
must
undergo
least
one
round
dna
replic
mitosi
synthesi
new
viru
begin
weiss
et
al
hiv
retroviru
wide
held
aetiolog
agent
aid
sever
hivassoci
mechan
describ
explain
cytopath
effect
cell
observ
vitro
far
none
mechan
observ
vivo
garri
mani
hiv
isol
obtain
aid
patient
poorli
cytopath
vitro
noncytopath
hiv
isol
associ
diseas
levi
usual
nondivid
lymphocyt
product
infect
retrovirus
like
hiv
antigen
mitogenactiv
one
infect
unactiv
cell
lead
incomplet
revers
transcript
hiv
rna
truncat
dna
copi
extrem
unstabl
halflif
h
zack
et
al
activ
hivinfect
lymphocyt
also
seem
necessari
induc
replic
hiv
viru
product
observ
lymphocyt
cultur
expos
antigen
wherea
viru
produc
absenc
antigen
stimul
fauci
ho
et
al
coomb
et
al
possibl
isol
hiv
peripher
blood
lymphocyt
pbl
hivseroposit
patient
cocultiv
freshli
activ
pbl
regardless
clinic
stage
infect
ho
et
al
coomb
et
al
howev
plasma
viraemia
found
correl
clinic
stage
infect
patient
xith
plasma
viraemia
hiv
antigen
either
serum
submit
juli
accept
juli
plasma
correl
found
amount
antigen
plasma
plasma
hiv
titr
coomb
et
al
cohort
data
show
time
increas
number
patient
preserv
high
titr
antibodi
without
detect
titr
antigen
develop
aid
explan
offer
find
failur
detect
viral
antigen
patient
cheingsongpopov
et
al
least
one
viru
current
known
major
target
cell
hiv
human
infect
quit
common
gener
popul
fact
sever
strain
directli
cytopath
pbl
purifi
lymphocyt
takahashi
et
al
levi
et
al
carrigan
et
al
shown
preferenti
tropism
activ
cell
addit
cytokin
infect
cultur
stimul
product
lusso
et
ai
carrigan
et
al
featur
share
hiv
fauci
garri
howev
find
level
hiv
plasma
pbl
higher
previou
estim
reinforc
idea
hiv
direct
cytopath
effect
alon
may
suffici
explain
much
pathogenesi
aid
ho
et
al
coomb
et
al
baltimor
feinberg
let
us
consid
case
common
cold
caus
larg
number
virus
belong
less
four
differ
group
adeno
rhinocoxsacki
corona
virus
nevertheless
differ
virus
abl
caus
clinic
syndrom
cytopath
virus
share
main
target
cell
popul
fact
indirectli
suggest
case
hiv
may
someth
kill
common
target
cell
popul
explain
hiv
caus
aid
key
obviou
differ
hiv
hiv
retroviru
need
hostcel
activ
replic
herpesviru
independ
hostcel
activ
replic
hiv
replic
depend
activ
suppress
hiv
replic
achiev
suppress
activ
case
replic
control
mechan
target
activ
host
cell
viralinduc
diseas
may
due
immunopatholog
process
viral
lysi
develop
case
incub
period
relat
time
immunopatholog
event
result
diseas
period
viral
replic
situat
strength
viral
replic
directli
relat
sever
clinic
ill
incub
period
depend
mechan
diseas
produc
host
factor
virul
dosag
infect
agent
evan
current
pictur
hiv
infect
show
three
phase
short
acut
phase
high
level
viru
produc
chronic
phase
character
low
level
hiv
express
crisi
termin
phase
recrudesc
viral
replic
occur
baltimor
feinberg
clark
et
import
stress
earli
acut
phase
clinic
character
mild
flulik
mononucleosislik
syndrom
time
infect
hiv
onset
acut
clinic
ill
gener
week
clinic
ill
usual
last
week
symptom
selflimit
recur
resolut
unlik
symptom
associ
ebv
mononucleosi
follow
hiv
infect
intens
period
viral
replic
demonstr
eas
viral
isol
high
level
plasma
hiv
antigen
frequenc
hiv
isol
decreas
follow
seroconvers
plasma
level
hiv
decreas
undetect
level
antibodi
inhibit
synctium
format
vitro
antibodi
mediat
antibodydepend
cellular
cytotox
viral
infect
cell
develop
soon
seroconvers
find
suggest
immunolog
respons
primari
hiv
infect
favour
short
term
tindal
cooper
clark
et
al
howev
lymphocytosi
atyp
lymphocyt
observ
primari
hiv
infect
second
week
onset
ill
tindal
cooper
similar
lymphocytosi
characterist
primari
cytomegaioviru
cmv
epsteinbarr
viru
ebv
infect
ebv
infect
cell
shown
control
infect
kill
virusinfect
b
lymphocyt
suppress
viru
replic
svedmyr
jondal
increas
cell
number
primari
hiv
infect
occur
concomit
resolut
clinic
symptom
sharp
reduct
amount
plasma
hiv
antigen
cooper
et
al
report
first
week
primari
hiv
infect
decreas
respons
lymphocyt
antigen
mitogen
cooper
et
al
signific
decreas
circul
cell
time
western
blot
seroconvers
also
observ
reduct
cell
number
present
preced
period
western
blot
neg
howev
prior
western
blot
seroconvers
increas
cell
azidothymidin
azt
inhibitor
viral
revers
transcriptas
produc
signific
reduct
hiv
plasma
titr
compar
mean
plasma
titr
untreat
patient
aid
aidsrel
complex
ho
et
al
howev
spite
clear
effect
upon
hiv
replic
azt
produc
transient
increas
cell
number
true
level
cell
correl
diseas
progress
like
time
level
declin
damag
hot
immun
sy
tem
probabl
irrevers
baltimor
feinberg
profound
sole
characterist
hiv
infect
sever
cell
deplet
may
occur
patient
viscer
leishmaniasi
pneumocysti
carinii
pneumonia
absenc
hiv
infect
cozon
et
al
gautier
et
al
certain
hiv
titr
produc
chronic
phase
infect
low
exclud
caus
meaning
reduct
cell
number
proport
cell
infect
hiv
asymptomat
subject
low
although
high
proport
infect
cell
contain
replicationcompet
proviru
copi
fulli
compat
good
health
high
number
cell
blood
even
year
infect
hiv
brinchmann
et
al
lymph
node
shown
contain
averag
fewer
hiv
dna
copi
per
cell
evid
sequestr
destruct
larg
number
hivinfect
cell
lymph
node
shibata
et
import
question
whether
hivinfect
bone
marrow
stemprogenitor
cell
serv
signific
reservoir
viru
hivinfect
individu
howev
shown
infect
bone
marrow
stemprogenitor
cell
hiv
occur
rare
ever
vivo
thu
infect
stem
cell
major
sourc
persist
hiv
account
haematopoiet
suppress
davi
et
al
difficult
accept
cytopath
effect
hiv
individu
infect
cell
kill
suffici
number
cell
exceed
capac
gener
new
cell
remain
normal
ludyard
grossi
recent
report
viru
load
cell
asymptomat
individu
suggest
cell
like
lost
direct
consequ
infect
hiv
addit
mechan
may
contribut
deplet
cell
brinchmann
et
al
far
potenti
treatment
aid
design
intent
inhibit
suppress
hiv
replic
howev
current
evid
suggest
hiv
replic
activ
produc
mild
mononucleosislik
syndrom
steeper
et
al
tindal
cooper
thu
perhap
immun
reaction
trigger
tcell
activ
necessari
permit
hiv
replic
caus
final
lead
immunodefici
major
patholog
time
realiz
suppressor
cell
suitabl
mechan
limit
immun
respons
foreign
agent
foreign
agent
quickli
elimit
chronic
infect
parasit
infect
variou
type
establish
organ
transplant
nossal
exampl
selfreact
cell
matur
thymu
enter
peripheri
could
function
inhibit
cell
suppressionimmunoregul
selfreact
cell
encount
antigen
recogn
thu
lead
clonal
anergi
shown
clonal
anergi
account
antigenspecif
toler
induc
mice
rammense
et
al
also
shown
suppressor
cell
induc
clonal
anergi
cell
respond
mycgbaet
ium
lepra
antigen
vitro
fact
suggest
suppressor
cell
may
oper
interf
deliveri
costimulatori
signal
antigenstimul
cell
mueller
found
cell
hivinfect
subject
seroneg
control
abl
suppress
replic
hiv
acut
infect
cell
vitro
also
pbl
hivinfect
individu
suppress
partli
mediat
diffus
factor
direct
elimin
cell
cytotox
cell
activ
instead
viru
product
suppress
noteworthi
complet
suppress
viru
replic
achiev
vitro
even
low
number
cell
hivinfect
individu
walker
et
al
walker
levi
walker
et
al
suggest
tendenc
toward
excess
cell
necessari
effici
hiv
suppress
case
tcell
defect
observ
aid
patient
lymphocyt
elimin
purif
cell
test
prolifer
helper
function
sug
gest
restor
function
might
due
remov
suppressor
cell
margolick
et
al
hypergammaglobulinaemia
seen
mani
aid
patient
goe
idea
aid
directli
relat
tcell
death
one
would
expect
decreas
antibodi
product
decreas
number
function
helper
cell
shown
spontan
immunoglobulin
productien
et
al
also
observ
drop
number
cell
occur
seroconvers
sinc
observ
hivinfect
seroneg
subject
nevertheless
lower
ratio
observ
seroconvers
howev
caus
abnorm
low
number
cell
rather
elev
number
cell
imagawa
et
al
immunolog
abnorm
observ
hivinfect
homosexu
men
long
deplet
cell
marion
et
al
miedma
et
al
cohort
studi
relationship
tcell
count
progress
aid
shown
contrari
expect
progress
aid
frequent
hivinfect
individu
high
earli
tcell
count
anderson
et
al
presenc
spontan
suppressor
cell
activ
ssca
patient
aid
arc
found
cell
popul
appear
interact
produc
normal
augment
downregul
residu
tlymphocyt
function
even
face
helperinduc
tcell
deplet
katner
et
al
higher
level
ssca
found
patient
earli
clinic
aid
advanc
termin
diseas
patient
surviv
clinic
aid
one
year
lower
level
ssca
compar
control
ssca
seem
predict
diseas
progress
sinc
patient
arc
show
rise
ssca
progress
aid
blunt
ssca
progress
full
diseas
mullin
mayer
inhibitori
activ
hiv
replic
cell
seem
mediat
mechan
classic
virusspecif
mhc
cytotox
brinchmann
et
al
mice
possibl
isol
character
suppressor
tcell
clone
capabl
inhibit
antigeninduc
prolif
respons
helper
cell
clone
without
detect
cytotox
either
antigenpres
cell
respond
cell
inhibitori
activ
neither
antigenspecif
mhcrestrict
hisatsun
et
al
thu
final
recrudesc
hiv
replic
observ
termin
aid
could
repres
final
exhaust
host
immun
system
due
tcellmedi
chronic
oversuppress
end
downregul
even
tcell
activ
evid
suggest
suppressor
cell
particip
immunopathogenesi
aid
discuss
elsewher
laurenc
et
al
mullin
et
al
arandaanzaldo
mullin
mayer
thu
normal
clonal
anergi
mediat
noncytotox
suppressor
cell
antigenand
cellspecif
process
case
aid
could
face
suppressor
tcell
mediat
nonspecif
pananergi
may
affect
sort
tcell
popul
compar
prolif
respons
aid
patient
lymphocyt
respons
lymphocyt
hivseroneg
homosexu
control
found
decreas
prolif
respons
aid
lymphocyt
primarili
due
defici
signal
via
cell
membran
receptor
sinc
direct
stimul
follow
intracellular
stimulatori
pathway
normal
respons
furthermor
found
aid
lymphocyt
major
defect
receptor
express
lymphocyt
abl
produc
stimul
directli
via
intracellular
stimulatori
pathway
hofmann
et
al
thu
decreas
product
seen
aid
lymphocyt
must
explain
defect
central
inactiv
membranedepend
stimulatori
pathway
alreadi
propos
decreas
prolif
respons
observ
lymphocyt
hivinfect
individu
link
inhibit
major
step
lead
dna
synthesi
cell
prolifer
hofmann
et
ai
arandaanzaldo
studi
sever
laboratori
show
pbl
aid
patient
inhibit
vitro
helper
respons
pbl
noninfect
individu
solubl
factor
inhibit
normal
helper
function
detect
cultur
pbl
hivposit
patient
inhibitori
cell
suppress
factor
block
selfrestrict
helper
respons
without
affect
tbe
auogen
restrict
compon
mix
lymphocyt
reaction
respons
tcell
mitogen
laurenc
mayer
hofmann
eta
suggest
select
loss
selfrestrict
helper
function
due
solubl
factor
factor
produc
subset
pbl
arandaanzaldo
shearer
clerici
aid
patient
thymu
histolog
chang
suggest
prematur
involut
inflammatori
chang
similar
seen
graft
vs
host
diseas
gvhd
immun
abnorm
earli
hiv
infect
parallel
seen
call
immunostimulatori
gvh
reaction
observ
mice
lead
activ
suppressor
ceil
specif
inhibit
murin
helper
cell
shearer
et
al
shown
major
effect
gvhdinduc
suppressor
mice
inhibit
dna
synthesi
suppressor
block
prolifer
induc
receptormedi
stimul
exogen
ad
growth
factor
significantli
inhibit
either
lymphokin
secret
lymphokin
receptor
express
wall
et
al
observ
bear
strike
similar
made
pbl
fullblown
aid
patient
prolif
respons
cell
defect
respons
may
increas
addit
subnorm
level
hofmann
et
al
also
remark
tcellinduc
clonal
anergi
observ
mice
unrespons
cell
show
normal
densiti
membran
tcell
receptor
well
abil
express
receptor
parallel
situat
found
gvhd
aid
lymphocyt
unrespons
cell
clonal
anergi
fail
prolifer
produc
like
aid
lymphocyt
produc
direct
stimul
intracellular
pathway
hofmann
et
al
report
fulmin
viral
diseas
induc
r
strain
simian
immunodefici
viru
siv
affect
monkey
produc
patholog
chang
gastrointestin
tract
typic
immunolog
mediat
reaction
like
gvhd
martin
thu
antigenstimul
host
persist
activ
helper
tlymphocyt
popul
subject
downregul
activ
suppressor
tcell
popul
introduct
hiv
system
gener
new
popul
activ
cell
need
suppress
avoid
replic
spread
hiv
suppressor
cell
produc
solubl
factor
abl
stop
hiv
replic
inhibit
dna
replic
host
cell
block
entri
hivinfect
cell
phase
cell
cycl
two
mechan
mutual
exclus
suppressor
solubl
factor
abl
block
dna
replic
hivinfect
cell
also
noninfect
lymphocyt
hiv
replic
might
contain
control
time
combin
antibodymedi
mechan
cellmedi
suppress
produc
popul
latent
persist
hivinfect
lymphocyt
suscept
clonal
polyclon
activ
year
whichev
new
antigen
stimuli
host
shall
expos
lead
new
cycl
helper
tlymphocyt
suppress
mediat
cell
thu
gener
viciou
cycl
activationsuppressionactiv
etc
factor
block
effect
tcell
replic
critic
role
loss
equilibrium
activ
suppress
favour
highrisk
group
expos
continu
antigen
stimul
lead
state
immun
oversuppress
certain
tcell
subset
less
suscept
downregul
normal
homeostat
control
immun
network
take
lead
role
consequ
cell
first
lymphocyt
popul
declin
consequ
decreas
product
lymphokin
necessari
activ
macrophag
matur
effector
function
natur
constitut
killer
cell
final
even
tcell
number
declin
due
lack
appropri
helper
tlymphocyt
stimul
nevertheless
rel
number
cell
remain
elev
immunodepress
subject
exist
sever
model
virusinduc
immunodefici
mice
cat
cattl
monkey
weiss
although
none
clinic
syndrom
obs
ved
anim
model
complet
equival
human
aid
anim
model
remain
possibl
sourc
vivo
experiment
data
anim
model
suitabl
test
suggest
hypothesi
reduct
elimin
suppressor
cell
may
lead
clinic
improv
abrog
immunodefici
state
exampl
sever
experiment
immunodefici
induc
mice
murin
leukaemia
viru
mulv
replicationdefect
although
model
evid
viru
infect
murin
helper
cell
bcell
hyperplasia
hyperglobulinaemia
immunosuppress
observ
seem
depend
essenti
presenc
lymphocyt
sinc
defect
viru
affect
nude
mice
much
less
sever
aziz
et
al
current
evid
show
extrem
low
level
hiv
proviru
present
circul
pbl
hivinfect
person
lymphocyt
contain
proviru
express
viru
ho
et
al
schnittman
et
al
simmond
et
al
brinchmann
etal
thu
may
face
situat
observ
final
increas
percentag
infect
cell
aid
patient
consequ
clonal
growth
viru
replic
spread
shown
viral
replic
per
se
necessari
induc
murin
acquir
immunodefici
syndrom
strictli
helperfre
defect
mulv
abl
produc
syndrom
without
evid
viral
replic
huang
et
al
strike
observ
number
infect
cell
least
higher
diseas
mice
newli
infect
one
conclud
expans
infect
cell
popul
occur
cell
divis
reinfect
sinc
mice
found
harbour
viru
abl
replic
mous
cell
data
indic
expand
cell
popul
clonal
oligoclon
origin
singl
infect
cell
transform
gain
growth
advantag
infect
defect
retroviru
thu
suggest
interact
virusmodifi
cell
cell
immun
system
could
trigger
immunodefici
huang
et
ai
attempt
use
immunosuppress
drug
like
cyclosporin
treatment
aid
partial
benefici
effect
observ
andrieu
et
al
known
precursor
cell
readili
inactiv
agent
destroy
block
rapidli
divid
cell
cyclophosphamid
cyclosporin
matur
cell
resist
agent
socal
tsi
cell
abl
produc
suppressor
solubl
factor
respons
antigen
particularli
shortliv
henc
system
antibodi
product
cellmedi
immun
strongli
suppress
antigen
elicit
cell
elimin
blockag
induc
cell
either
low
dose
cyclosporin
cyclophosphamid
time
antigen
administ
result
enhanc
immun
respons
agent
given
antigen
elicit
enough
cell
perman
enhanc
result
davi
et
al
thu
especi
noteworthi
murin
acquir
immunodefici
syndrom
maid
associ
prolifer
target
cell
infect
replicationdefect
strain
mulv
prevent
normal
tcell
function
restor
well
mice
treatment
cyclophosphamid
antineoplast
drug
like
arabinosylcytosin
rr
trd
l
l
l
e
l
rl
r
v
lsd
lt
tllot
v
yk
iiiiiikiik
ahiliiiii
tk
k
u
earli
day
inocul
mice
defect
mulv
simard
jolicoeur
paradox
effect
otherwis
immunosuppress
drug
may
explain
least
part
fact
low
dose
cyclophosphamid
known
preferenti
elimin
suppressor
cell
lymphocyt
popul
shand
well
know
possibl
isol
differ
hiv
strain
differ
biolog
properti
hivinfect
person
saag
et
al
chiodi
et
al
perhap
strain
quasispeci
virus
like
mulv
hiv
either
replicationdefici
replicationdefect
abl
trigger
perpetu
ambigu
immun
respons
suppressor
cell
aim
curtail
expans
infect
cell
popul
domin
role
meyerhan
et
al
like
suppressor
factor
produc
suppressor
cell
abl
stop
hiv
replic
inhibit
dna
replic
host
cell
block
entri
hivinfect
cell
phase
cell
cycl
howev
also
possibl
suppressor
factor
would
abl
distinguish
ceil
latent
infect
cell
activ
express
viru
cell
expand
number
due
growth
advantag
confer
replicationdetect
quasispeci
viru
question
net
result
would
downregul
inhibit
whole
rang
target
cell
popul
independ
infect
statu
may
specul
fulli
replicationcompet
strain
hiv
would
produc
balanc
immun
respons
like
one
seen
classic
viral
infect
cellmedi
immun
abl
restrict
spread
viru
infectedcel
popul
without
caus
harm
host
un
pour
le
lymphocyt
dan
la
pathogens
du
sida
de
preuv
cliniqu
et
sont
avanc
pour
corrobor
lhypoths
que
le
lymphocyt
visant
la
suppress
de
la
tion
du
vih
dan
le
cellul
pourraient
jouer
un
rfle
import
dan
la
pathogens
du
sida
en
provoqu
direct
une
diminut
du
nombr
de
lymphocyt
de
modul
en
vue
de
tester
cett
hypoths
sont
motscld
sida
hiv
lymphocyt
immunosuppress
anergi
clonal
maladi
du
greffon
contr
lhfte
expgrimental
mise
au
point
sinc
submiss
articl
report
cyclosporin
protect
mice
immunodefici
diseas
induc
replicationdefect
mulv
cerni
et
ai
eur
j
immunol
